News

Now, it’s worth noting Stock Advisor’s total average return is 1,041% — a market-crushing outperformance compared to 183 % ...
Gilead Sciences (GILD) faces stock pressure as changes to the U.S. Preventive Services Task Force could impact PrEP drug ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $113.03, denoting a -2.73% move from the preceding trading day.
Mount Gilead Missionary Baptist Church will host their second annual free market this weekend for those who need it.
BMO Capital opined on Monday that recent reports indicating Robert F. Kennedy Jr.'s plan to remove all members of the U.S.
Shares of Gilead Sciences (NASDAQ:GILD) dropped 2.8% Monday morning after reports emerged that U.S. Health and Human Services ...
Lenacapavir can prevent 100 percent of HIV infections after just two injections per year, but getting it to SA could be a ...
Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...
Nontargeted hepatitis C screening leads to higher testing and diagnosis rates in the emergency department than targeted, risk ...
Appointments, promotions and other news at ArchCare, DIGroup Architecture, Edward Don & Company, Emerald Communities, Humphreys & Partners Architects, K4Connect, LeadingAge Illinois, LeadingAge PA, ...
In celebration of the World Hepatitis Day (28 July), HCSA Community Services and Tan Tock Seng Hospital (TTSH), ...